Markets · Global Equities · US

Arbutus Biopharma Corp ABUS

Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.

• Revenue TTM 191.41M
• EBITDA TTM 156.80M
• Net debt -92.63M
• ND/EBITDA -0.59
• EBITDA/interest 1823.3
• ROE 0.62
• Implied band A

All countries